Menu
中文

Overview

Performance

Growth of $10,000

Holdings

Fund Documents

Overview

Investment Strategy:

KMED seeks to provide investment results that, before fees and expenses, track the performance of the Solactive Emerging Markets Healthcare Index. The index seeks to track the equity market performance of companies engaged in the health care sector in various emerging markets. The issuers include small-cap, mid-cap, and large-cap companies involved in hospital management, healthcare management, pharmaceutical manufacturing, and biotechnology, among other sub-industries.

Emerging Market Healthcare Sector Highlights:

  • By 2040, emerging market countries on average are projected to increase healthcare spending as percent of GDP by 24.4% compared to just 9.8% in developed markets over the same time period1.
  • In emerging markets, rapid urbanization and rising income is fueling growth in the demand for healthcare services and treatments.
  • Cases of non-communicable diseases (NCDs) such as diabetes and cancer are rising steadily in emerging market countries, presenting a growth opportunity for innovators in the healthcare space.
  • Emerging markets governments are enacting policies such as India’s “National Health Protection Mission” and China’s “Healthy China 2030 Plan” to meet the growing demand for healthcare.

KMED features:

  • Exposure to the Emerging Market healthcare industry with a low correlation to US healthcare equities. Specifically: pharmaceuticals, biotechnology, healthcare administration services, and medical equipment.
  • Access to emerging market innovators in healthcare and pharmaceutical research.
  • Exposure to companies that benefit from the growing and aging EM populations.

1.) Dieleman, Joseph L et al., “Future and potential spending on health 2015–40: development assistance for health, and government, prepaid private, and out-of-pocket health spending in 184 countries”, The Lancet , Volume 389 , Issue 10083 , 2005 - 2030.

Fund Details

Data as of 03/23/2023
Ticker KMED
Primary Exchange NYSE
CUSIP 500767819
ISIN US5007678197
Net Assets $2,105,218
Total Annual Fund Operating Expense 0.81%
Inception Date 8/29/18
Distribution Frequency

Trending Funds:

KMLM

KFA Mount Lucas Managed Futures Index Strategy ETF

KMET

KraneShares Electrification Metals Strategy ETF

KBUY

KraneShares CICC China Consumer Leaders Index ETF

KHYB

KraneShares Asia Pacific High Income Bond ETF

Explore All Products

Premium Discount Chart

Daily Performance

Data as of 03/23/2023
Daily Net Asset Value (NAV) and Market Price
NAV $21.05
NAV Daily Change 0.48%
Market Price $21.06
Market Price Daily Change 0.14%
30 Day Median Bid/Ask Spread
0.62%
The ETF’s 30 Day Median Bid-Ask Spread is calculated by identifying the ETF’s national best bid and national best offer ("NBBO") as of the end of each 10 second interval during each trading day of the last 30 calendar days and dividing the difference between each such bid and offer by the midpoint of the NBBO. The median of those values is identified and that value is expressed as a percentage rounded to the nearest hundredth.
Distributions

Performance History

Cumulative %
Data as of: 02/28/2023
Fund NAV Closing Price Index
1 Month -8.27% -9.20% -8.31%
3 Month -2.83% -4.60% -2.69%
6 Month -2.65% -2.30% -2.32%
Since Inception -13.70% -13.98% -11.54%
Avg Annualized %
Data as of month end: 02/28/2023
Fund NAV Closing Price Index
1 Year -15.47% -16.05% -15.40%
3 Year -0.79% -0.57% -0.37%
Since Inception -3.22% -3.29% -2.69%
Avg Annualized %
Data as of quarter end: 12/31/2022
Fund NAV Closing Price Index
1 Year -21.48% -21.11% -21.59%
3 Year -0.70% -0.42% -0.17%
Since Inception -2.44% -2.47% -1.90%

The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.

Topics:

Growth of $10,000

Data as of 03/23/2023

The Growth of $10,000 chart reflects an initial investment of $10,000 on the day prior to the selected time period and assumes reinvestment of dividends and capital gains. For the growth of $10,000 chart since inception, the initial investment of $10,000 is instead made on the inception date of the Fund. Fund expenses, including management fees and other expenses were deducted. The growth of a $10,000 investment in the fund is hypothetical and for illustration purposes only.

Top 10 Holdings

Data as of 03/24/2023 Full Holdings .CSV
Rank Name % of Net Assets Ticker Identifier Shares Held Market Value($)
1 INTL HOLDING CO PJSC 4.77% IHC AEI000201014 922 99,419
2 SHENZHEN MINDR-A 4.67% 300760 CNE100003G67 2,200 97,383
3 SUN PHARMACEUTICAL INDUS 4.54% SUNP INE044A01036 8,025 94,659
4 SAMSUNG BIOLOGICS CO LTD 4.34% 207940 KR7207940008 147 90,516
5 CELLTRION INC 4.17% 068270 KR7068270008 734 87,055
6 AIER EYE HSPTL-A 3.50% 300015 CNE100000GR6 16,423 72,935
7 BANGKOK DUSIT-F 3.31% BDMS/F TH0264A10Z12 80,600 69,065
8 JIANGSU HENGRU-A 3.19% 600276 CNE0000014W7 10,948 66,475
9 IHH HEALTHCARE BHD 2.98% IHH MYL5225OO007 47,500 62,110
10 WUXI BIOLOGICS CAYMAN INC 2.77% 2269 KYG970081173 9,281 57,816

Holdings are subject to change.

Fund Documents

©2023 Krane Funds Advisors, LLC
280 Park Avenue, 32nd Floor, New York, NY 10017

Carefully consider the Funds’ investment objectives, risk factors, charges and expenses before investing. This and additional information can be found in the Funds’ full and summary prospectus, which may be obtained by visiting: KWEB, KLIP, KBA, KURE, KFYP, KRBN, KEUA, KCCA, KGRN, KALL, KBND, KHYB, OBOR, KARS, KEMQ, KMED, KEMX, KESG, KSTR, KFVG, KBUY, KTEC, KGRO, KGHG, KSET, KDIV, KMET, IVOL, KMLM, BNDD, KVLE. Read the prospectus carefully before investing. Please note these links also contain the Funds' top ten holdings, performance, and other important information.

Risk Disclosures:

Investing involves risk, including possible loss of principal. There can be no assurance that a Fund will achieve its stated objectives. Indices are unmanaged and do not include the effect of fees. One cannot invest directly in an index.

This information should not be relied upon as research, investment advice, or a recommendation regarding any products, strategies, or any security in particular. This material is strictly for illustrative, educational, or informational purposes and is subject to change. Certain content represents an assessment of the market environment at a specific time and is not intended to be a forecast of future events or a guarantee of future results; material is as of the dates noted and is subject to change without notice.

The Fund may invest in derivatives, which are often more volatile than other investments and may magnify the Fund’s gains or losses. A derivative (i.e., futures/forward contracts, swaps, and options) is a contract that derives its value from the performance of an underlying asset. The primary risk of derivatives is that changes in the asset’s market value and the derivative may not be proportionate, and some derivatives can have the potential for unlimited losses. Derivatives are also subject to liquidity and counterparty risk. The Fund is subject to liquidity risk, meaning that certain investments may become difficult to purchase or sell at a reasonable time and price. If a transaction for these securities is large, it may not be possible to initiate, which may cause the Fund to suffer losses. Counterparty risk is the risk of loss in the event that the counterparty to an agreement fails to make required payments or otherwise comply with the terms of the derivative.

The ability of the Fund to achieve its respective investment objectives is dependent, in part, on the continuous availability of A Shares and the ability to obtain, if necessary, additional A Shares quota. If the Fund is unable to obtain sufficient exposure to limited availability of A Share quota, the Fund could seek exposure to the component securities of the Underlying Index by investment in other types of securities. The Fund is subject to political, social or economic instability within China which may cause decline in value. Emerging markets involve heightened risk related to the same factors as well as increase volatility and lower trading volume. Fluctuations in currency of foreign countries may have an adverse effect to domestic currency values. Narrowly focused investments typically exhibit higher volatility. The Fund’s assets are expected to be concentrated in a sector, industry, market, or group of concentrations to the extent that the Underlying Index has such concentrations. The securities or futures in that concentration could react similarly to market developments. Thus, the Fund is subject to loss due to adverse occurrences that affect that concentration.

In addition to the normal risks associated with investing, investments in smaller companies typically exhibit higher volatility. KMED is non-diversified.

ETF shares are bought and sold on an exchange at market price (not NAV) and are not individually redeemed from the Fund. However, shares may be redeemed at NAV directly by certain authorized broker-dealers (Authorized Participants) in very large creation/redemption units. The returns shown do not represent the returns you would receive if you traded shares at other times. Shares may trade at a premium or discount to their NAV in the secondary market. Brokerage commissions will reduce returns. Beginning 12/23/2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn't available, the midpoint between the national best bid and national best offer ("NBBO") as of the time the ETF calculates the current NAV per share. Prior to that date, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time.

The KraneShares ETFs, KFA Funds ETFs, and KraneShares Mutual Funds are distributed by SEI Investments Distribution Company (SIDCO), 1 Freedom Valley Drive, Oaks, PA 19456, which is not affiliated with Krane Funds Advisors, LLC, the Investment Adviser for the Funds, or any sub-advisers for the Funds.

Privacy Policy

Whistleblower Policy

You are now leaving KraneShares.com

Hyperlinks on this website are provided as a convenience and we disclaim any responsibility for information, services or products found on the websites linked hereto.

Click here to continue

Invest in KMED Through Your Broker

You are now leaving KraneShares.com. Hyperlinks on these websites are provided as a convenience and we disclaim any responsibility for information, services or products found on the websites linked hereto.